CA - Investors Have Another Chance To Sell Curaleaf
2024-03-17 09:02:01 ET
Summary
- Curaleaf reported Q4 results that met expectations, with revenue of $345 million and adjusted EBITDA of $83 million.
- However, revenue and EBITDA growth were not impressive, and concerns about the company's balance sheet and cash flow increased.
- Analysts have revised their outlook for Curaleaf, with lower expectations for revenue and adjusted EBITDA growth in the future.
I wrote about Curaleaf ( OTCPK:CURLF ) being a bad cannabis investment in early January, and the stock, after the 22% gain on Friday, is now up a little from then. I rated it a strong sell, and I continue to have a very negative view on the stock....
Investors Have Another Chance To Sell Curaleaf